Is aspirin safe for patients with heart failure?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

21 citing papers in PubMed.

1. Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Management of the Underlying Etiologies and Comorbidities of Heart Failure.Korean circulation journal · 2023
   Review
2. Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Management of the Underlying Etiologies and Comorbidities of Heart Failure.International journal of heart failure · 2023
   Review
3. Fighting against sudden death: a single or multidisciplinary approach.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2006
   Review
4. Does aspirin attenuate the beneficial effect of ACE inhibitors in elderly people with heart failure?Drugs & aging · 2005
   Article
5. Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention.Drugs · 2003
   Review
6. Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors.Journal of human hypertension · 2002
   Article
7. Chronic aspirin is effective--if data are massaged sufficiently.BMJ (Clinical research ed.) · 2002
   Article
8. Preventing atherosclerotic events with aspirin.BMJ (Clinical research ed.) · 2002
   Article
9. Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.British journal of clinical pharmacology · 2002
   Article
10. The angiotensin-converting enzyme inhibitor and aspirin interaction in congestive heart failure: fear or reality?Current cardiology reports · 2001
    Review
11. Aspirin and ACE-inhibitors: for wedding or funeral?Journal of thrombosis and thrombolysis · 2001
    Review
12. Interaction between aspirin and ACE inhibitors in patients with heart failure.Drug safety · 2001
    Review
13. Sarcoidosis and the Heart.Current treatment options in cardiovascular medicine · 2000
    Article
14. Heart failure: Part II.The Western journal of medicine · 1999
    Review
15. Choosing the most appropriate treatment for stable angina. Safety considerations.Drug safety · 1998
    Review
16. Optimal treatment of heart failure in the elderly.Drugs & aging · 1997
    Review
17. Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy.Postgraduate medical journal · 1996
    Review
18. Neuroendocrine activation after myocardial infarction: causes and consequences.Heart (British Cardiac Society) · 1996
    Review
19. ACE inhibitors unmask incoordinate diastolic wall motion in restrictive left ventricular disease.Heart (British Cardiac Society) · 1996
    Article
20. Is aspirin safe in heart failure? more data.Heart (British Cardiac Society) · 1996
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

9 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as